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The title compound, C5H4N2O4H2O, a uracil derivative,
contains several important functional groups, which give rise
to its use in biomedical applications. The crystal structure
consists of molecules held together by extensive intermolec-
ular hydrogen bonding between neighbouring pyrimidine
rings and between the acid groups and water molecules,
resulting in a layered sheet structure. The asymmetric unit
contains two molecules of the carboxylic acid and two water
molecules.
Comment
Pyrimidines, especially those incorporating the uracil func-
tional group, are known for their applications in biomedical
studies (Iltzsch & Tankersley, 1994; Javaid et al., 1999), for
example the use of uracil derivatives as antithyroid drugs as
well as enzyme inhibitors. The study of the title compound, (I),
may offer useful leads in relation to previously studied uracil
compounds, helping to improve and further our understanding
of drug design.
It is known that the 5±6 double bond of uracil and uracil
derivatives such as thiouracils is particularly reactive, espe-
cially towards nucleophiles; the range of reagents used for
selective reduction of the carbonyl functional group at posi-
tion 5 of the aromatic ring without reducing the double bond is
relatively small. It is also possible to reduce the carbonyl ester
at position 5 of the ring without affecting the aromaticity (5±6
double bond) of the ring. The choice of reaction medium has
been found to be of importance (Gosh et al., 1984; Pal, 1978),
as it has been established that the reactivity of a carboxylic
acid is greater than that of an ole®nic bond towards certain
reagents in tetrahydrofuran (THF). Hence, as well as the
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solubility factor in¯uencing the choice of the reaction medium,
THF was the reagent of choice for the conversion of the ester
functional group to the corresponding acid and alcohol.
The asymmetric unit of the title compound contains two
molecules of the carboxylic acid and two water molecules.
Bond lengths and angles are typically in accord with values for
known uracil compounds. The CÐO bond lengths are in the
range 1.216 (3)±1.307 (3) AÊ , while the aromatic CÐC and CÐ
N distances are in the range 1.345 (3)±1.452 (3) AÊ .
Inspection of the structure shows hydrogen-bonding inter-
actions with the surrounding water molecules. These interac-
tions cause stacking of the molecules, giving a layered sheet
structure (Figs. 2 and 3). Examination of the structure (Fig. 1)
shows that there are intermolecular hydrogen-bond interac-
tions between the acid groups and the water molecules [O2Ð
H1  O9 = 2.537 (3) AÊ and O6ÐH7  O10 = 2.502 (4) AÊ ].
The exceptionally long O2ÐH1 and O6ÐH7 distances
[1.15 (3) AÊ ] indicate that the acid protons are probably delo-
calized between O2 and O9, and between O6 and O10. There
are also intermolecular NÐH  O interactions between
neighbouring pyrimidine moieties.
It is interesting to note that the hydrogen at the end of the
acid group does not form intramolecular hydrogen bond with
the oxygen on the pyrimidine ring. Instead it forms inter-
molecular bonds with the water molecules that are present.
Study of the two-dimensional cross-section in Fig. 3 shows
the layering and the sheet-like formation. The shortest out-of-
plane distance of the centroid of one pyrimidine ring to the
mean plane of the next pyrimidine ring sitting above or below
it is 3.104 (5) AÊ . The undulation of the sheets is caused by the
rather ¯exible and large carbonyl functional groups attached
to the aromatic ring, which is otherwise approximately planar.
The two acid molecules are found to be signi®cantly different
in conformation. The dihedral angle between the planar
pyrimidine ring and the protruding acid group is 12.24 (9) for
one (C2/C3/N1/C4/N2/C5 and C2/C1/O1/O2) and 1.24 (8) for
the other (C7/C8/N4/C9/N3/C10 and C7/C6/O5/O6). Neigh-
bouring symmetry-independent pyrimidine rings are not
exactly coplanar, the dihedral angle being 12.28 (7); these
effects together produce the slight wave in the structure.
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Figure 1
An ORTEP-3 (Farrugia, 2001) diagram of (I), showing 50% probability
ellipsoids and the atom-labeling scheme. Hydrogen-bonding interactions
are shown as dashed lines.
Figure 2
Packing diagram of (I), viewed along the c axis.
Figure 3
Packing diagram of (I), viewed perpendicular to b in the (101) plane.
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Experimental
In an attempt to produce a lanthanide complex of ethyl 2,4-dioxo-
1,2,3,4-tetrahydropyrimidine-5-carboxylate, (II), the title compound
was produced. Compound (II) (0.50 g, 2.71 mmol) was dissolved in
THF, terbium nitrate hexahydrate (0.62 g, 1.35 mmol) was added and
the resulting solution stirred for 24 h at ambient temperature. The
title compound was obtained by slow evaporation of the reaction
mixture. Analysis found: C 38.43, H 2.58, N 17.91%; calc for
C5H4N2O4: C 38.46, H 2.56, N 17.95%.
Crystal data
C5H4N2O4H2O
Mr = 174.11
Monoclinic, P21=c
a = 7.876 (2) AÊ
b = 20.352 (4) AÊ
c = 8.664 (2) AÊ
 = 101.87 (1)
V = 1359.1 (5) AÊ 3
Z = 8
Dx = 1.702 Mg m
ÿ3
Mo K radiation
Cell parameters from 16 902
re¯ections
 = 1.0±27.5
 = 0.16 mmÿ1
T = 298 (1) K
Block, pale yellow
0.16  0.16  0.08 mm
Data collection
Bruker SMART CCD
diffractometer
! scans
Absorption correction: none
16 902 measured re¯ections
3154 independent re¯ections
2050 re¯ections with F 2 > 2(F 2)
Rint = 0.032
max = 27.5

h = ÿ10! 10
k = ÿ26! 23
l = ÿ11! 10
Re®nement
Re®nement on F
R = 0.045
wR = 0.047
S = 1.09
3154 re¯ections
265 parameters
All H-atom parameters re®ned
w = 1/[0.0002Fo
2 + (Fo
2) + 0.015]
(/)max < 0.001
max = 0.29 e AÊ
ÿ3
min = ÿ0.24 e AÊ ÿ3
Table 1
Hydrogen-bonding geometry (AÊ , ).
DÐH  A DÐH H  A D  A DÐH  A
O2ÐH1  O9 1.15 (3) 1.39 (3) 2.537 (3) 175 (3)
N2ÐH3  O5i 0.87 (4) 1.91 (4) 2.775 (3) 174 (3)
N1ÐH4  O7 0.88 (2) 1.98 (2) 2.852 (3) 170 (2)
O9ÐH5  O4ii 0.90 (5) 1.94 (4) 2.826 (3) 171 (4)
O9ÐH6  O6ii 0.95 (4) 2.16 (4) 2.932 (3) 137 (3)
O9ÐH6  O7ii 0.95 (4) 2.00 (4) 2.795 (3) 140 (3)
O6ÐH7  O10 1.15 (3) 1.36 (3) 2.502 (4) 170 (3)
N3ÐH9  O1iii 0.83 (2) 1.96 (2) 2.768 (3) 168 (3)
N4ÐH10  O3 0.87 (4) 2.03 (4) 2.886 (3) 169 (3)
O10ÐH11  O2iv 0.92 (4) 2.26 (4) 2.947 (3) 131 (3)
O10ÐH11  O3iv 0.92 (4) 1.97 (4) 2.776 (3) 145 (4)
O10ÐH12  O8iv 0.95 (4) 1.85 (4) 2.795 (3) 174 (4)
Symmetry codes: (i) ÿx; 12 y; 12ÿ z; (ii) 1 x; y; 1 z; (iii) 1ÿ x; yÿ 12; 32ÿ z; (iv)
xÿ 1; y; zÿ 1.
All H atoms were located in difference Fourier syntheses and were
re®ned isotropically.
Data collection: SMART (Bruker, 1998); cell re®nement: SAINT
(Bruker, 1999); data reduction: SAINT and CrystalStructure (Rigaku/
MSC, 2003); program(s) used to solve structure: SHELXS97 (Shel-
drick, 1997); program(s) used to re®ne structure: CRYSTALS
(Watkin et al., 1996); molecular graphics: ORTEP-3 for Windows
(Farrugia, 2001); software used to prepare material for publication:
CrystalStructure.
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